Fluctuations in Stock Market as Viking Therapeutics Experiences Gap Down

Viking Therapeutics, Inc. (NASDAQ:VKTX) experienced a gap down in the stock market, with analysts closely monitoring the company and upgrading it to a ‘sell’ rating. Amidst this, the market continues to observe promising weight-loss drugs from biotechs, contributing to the dynamic landscape of the stock market.